Tag: GPN Vaccines
South Australian-made pneumococcal vaccine to undergo human trials
GPN Vaccines, a South Australian biotech company, has successfully developed a new universal vaccine that targets a pneumonia-causing bacterium.
Developed in collaboration with the University...
SA biotech firm wins State Government grant to trial low-cost pneumococcal vaccine
South Australian biotech company GPN Vaccines has secured a $1 million State Government grant to complete its first-in-human clinical trials for a more effective and lower...
Featured Article
Australian manufacturing in 2025: Challenges and pathways to progress
The Australian manufacturing sector, long considered the backbone of the nation’s economy, is standing at a crossroads in 2025.
